Utilization and Outcomes Associated With Intravascular Ultrasound during Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)

医学 血管内超声 危险系数 放射科 腔内修复术 腹主动脉瘤 主动脉瘤 动脉瘤 内科学 外科 心脏病学 置信区间
作者
Ramya Mosarla,Patrick Heindel,Mohamad A. Hussain,Marc L. Schermerhorn,Toshiki Kuno,Mario D’Oria,Siling Li,Eric A. Secemsky
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
标识
DOI:10.1161/circinterventions.124.014332
摘要

BACKGROUND: Intravascular ultrasound (IVUS) use in aortic endovascular interventions, including thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR), may have similar benefits to those seen in coronary and peripheral interventions, but limited utilization and outcome data exist. METHODS: Centers for Medicare and Medicaid Services claims data were used to identify patients undergoing TEVAR and EVAR from 2016 to 2023. Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death. Cox regression was used to estimate weighted hazard ratios. RESULTS: A total of 136 540 patients underwent TEVAR and EVAR, of which 9.8% (13 364) used IVUS. IVUS use increased slightly from 2016 to 2023, driven more by use in TEVAR compared with EVAR, and was higher in academic settings, with Medicare and Medicaid dual enrollment, in the West, with dissections, with malperfusion and for elective procedures. IVUS was associated with a lower risk of the primary outcome at 30-days (hazard ratio, 0.80 [95% CI, 0.73–0.89]; P <0.001) and 6-months (hazard ratio, 0.93 [95% CI, 0.87–0.99]; P =0.022) for all-comers. Subgroup analysis suggested lower risks of the primary outcome with IVUS use for aneurysm driven by the abdominal segment, malperfusion, thoracoabdominal dissection with malperfusion, thoracoabdominal repair, and chronic kidney disease. CONCLUSIONS: IVUS use has increased slightly in TEVAR and EVAR with heterogeneity in use. IVUS implementation during TEVAR and EVAR was associated with improved early and mid-term outcomes, particularly in certain subsets.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
lilin发布了新的文献求助30
1秒前
小草发布了新的文献求助10
1秒前
英俊的宝川完成签到,获得积分20
2秒前
Freya发布了新的文献求助10
3秒前
jfaioe完成签到,获得积分10
4秒前
5秒前
Vanff发布了新的文献求助10
5秒前
风轻云淡发布了新的文献求助10
7秒前
ZDddd完成签到,获得积分10
7秒前
望北完成签到 ,获得积分0
7秒前
寒冷不言应助凯k采纳,获得20
9秒前
orixero应助hhhh采纳,获得10
11秒前
12秒前
多情的香菇完成签到,获得积分10
15秒前
领导范儿应助cds采纳,获得10
15秒前
江南第一奶龙完成签到,获得积分20
16秒前
12376应助Juli采纳,获得10
16秒前
17秒前
黄紫红发布了新的文献求助10
17秒前
ccm完成签到,获得积分10
20秒前
21秒前
21秒前
23秒前
迷人寒梦发布了新的文献求助10
23秒前
Tiansy发布了新的文献求助10
26秒前
cds发布了新的文献求助10
26秒前
边城小子完成签到,获得积分10
27秒前
28秒前
29秒前
风轻云淡完成签到,获得积分10
29秒前
30秒前
北沐城歌完成签到,获得积分10
30秒前
充电宝应助晨纯采纳,获得10
30秒前
31秒前
好运连连完成签到,获得积分10
31秒前
com完成签到,获得积分10
32秒前
34秒前
lingzhi发布了新的文献求助10
34秒前
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Malcolm Fraser : a biography 700
Handbook of Optical Systems,Volume 6:Advanced Physical Optics 666
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6514839
求助须知:如何正确求助?哪些是违规求助? 8308222
关于积分的说明 17755274
捐赠科研通 5616651
什么是DOI,文献DOI怎么找? 2924781
邀请新用户注册赠送积分活动 1901815
关于科研通互助平台的介绍 1763137